₹139.95
−0.74%NSE close, 16 Nov 2026
−51.41%
VAIDYA SANE AYUR LAB is a small cap company, listed on NSE SME under the symbol MADHAVBAUG. At ₹139.95 a share, the market values the whole company at ₹147 crore. NSE SME is the exchange's platform for small and medium companies, which report their results every half year.
In FY26, it reported sales of ₹107 crore and a net profit of ₹9 crore, an operating margin of 14.4%. Over the last three years, sales grew 25.9% a year and net profit grew 62.4% a year.
The market values the company at 16.4 times its profit over the last twelve months and 2.05 times its book value; its return on equity is 12.5% and it has almost no borrowings.
Promoters hold 66.34% of the shares. Foreign institutions hold 0.00%, and domestic institutions, mutual funds among them, 0.00%.
Over the past year the share price has fallen 47.0%, and it is 58.2% below its 52-week high.
Listed on NSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
₹ crore. Consolidated figures.
| Line | 6M to Mar 2023 | 6M to Sep 2023 | 6M to Mar 2024 | Sep 2024 | 6M to Mar 2025 | 6M to Sep 2025 | 6M to Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 99.2 |
The financial results for the period ended September 30, 2026.
Has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__
A copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
| 48.2 |
| 41.8 |
| 48.1 |
| 49.9 |
| 57.0 |
| Expenses | 91.3 | 48.4 | 46.4 | 36.0 | 40.3 | 41.3 | 50.2 |
|---|
| Operating profit | 7.9 | 2.7 | 1.8 | 5.8 | 7.7 | 8.6 | 6.8 |
|---|
| Operating margin | 7.9% | 5.2% | 3.8% | 13.8% | 16.1% | 17.3% | 11.9% |
|---|
| Other income | 1.4 | 0.6 | 1.1 | 0.8 | 1.0 | 1.0 | 1.4 |
|---|
| Interest | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.1 | 0.8 |
|---|
| Depreciation | 2.6 | 1.6 | 1.6 | 1.9 | 2.4 | 3.0 | 3.1 |
|---|
| Profit before tax | 6.4 | 1.6 | 1.3 | 4.6 | 5.2 | 6.5 | 4.3 |
|---|
| Tax | 1.6 | 0.4 | 0.5 | 1.3 | 1.8 | 1.6 | 0.2 |
|---|
| Net profit | 4.8 | 1.2 | 0.8 | 3.3 | 3.4 | 4.8 | 4.2 |
|---|
| EPS (₹) | 4.60 | 1.12 | 0.76 | 3.59 | 3.17 | 4.56 | 3.95 |
|---|
₹ crore, financial years to March.
| Line | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales | 53.6 | 99.3 | 89.9 | 107 |
| Expenses | 49.9 | 94.8 | 76.4 | 91.5 |
| Operating profit | 3.7 | 4.5 | 13.5 | 15.4 |
| Operating margin | 6.9% | 4.5% | 15.0% | 14.4% |
| Other income | 0.5 | 1.8 | 1.9 | 2.4 |
| Interest | 0.1 | 0.3 | 0.1 | 0.9 |
| Depreciation | 1.4 | 3.1 | 4.2 | 6.1 |
| Profit before tax | 2.7 | 2.9 | 9.9 | 10.8 |
| Tax | 0.6 | 0.9 | 2.7 | 1.8 |
| Net profit | 2.1 | −0.0 | 7.2 | 9.0 |
| EPS (₹) | 1.99 | 1.88 | 6.76 | 8.51 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
Margins, returns, debt, tax and cash.
| Line | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Net margin | 3.9% | -0.0% | 8.0% | 8.4% |
| Operating margin | 6.9% | 4.5% | 15.0% | 14.4% |
| Return on equity | – | – | 11.5% | 12.5% |
| Return on capital employed | – | – | 15.6% | 15.7% |
| Return on assets | – | – | 9.4% | 8.6% |
| Debt to equity | – | – | 0.02 | 0.04 |
| Interest coverage | 39.60 | 12.40 | 100.00 | 13.70 |
| Debt to assets | – | – | 0.02 | 0.02 |
| Current ratio | – | – | 2.70 | 3.99 |
| Quick ratio | – | – | 2.36 | 3.66 |
| Cash ratio | – | – | 0.21 | 0.04 |
| Asset turnover | – | – | 1.17 | 1.02 |
| Fixed asset turnover | – | – | 4.19 | 4.87 |
| Inventory turnover | – | – | 4.50 | 5.20 |
| Receivables turnover | – | – | 11.90 | 10.50 |
| Gross margin | – | – | 81.4% | 82.3% |
| Cash from operations to profit | 3.0% | – | 148.0% | 60.0% |
| Effective tax rate | 22.6% | 30.4% | 27.7% | 16.8% |
Proceedings of Annual General Meeting held on September 30, 2026
Reply to Query - Submission of PCS Certificate pursuant to NSE mail on SDD Non-Compliance
Notice of Annual General Meeting to be held on September 30, 2026
Outcome of Board Meeting held on September 04, 2026.
Outcome of Board Meeting held on July 24, 2026.
The Exchange had sought clarification from Vaidya Sane Ayurved Laboratories Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to…
Has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__